Mach7 Technologies (M7T) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
12 Jan, 2026Opening remarks and agenda
Meeting opened with introductions of board members, executive team, auditors, and an outline of the virtual meeting process, including voting and Q&A procedures.
Agenda included a review of the past year, CEO presentation on results and future focus, formal business, and shareholder Q&A.
Chair and CEO addressed the meeting, highlighting achievements and strategic direction for FY25.
Financial performance review
Achieved record sales orders of AUD 61.3 million, up 52% on prior period, with renewals accounting for 61% of total, and revenue of AUD 29.1 million.
Recurring revenue reached AUD 22 million, up nearly 30% from June 2023, representing 72% of total revenue, up from 54% in FY23.
Positive operating cashflow of AUD 3.5 million and cash on hand at 30 June 2024 was AUD 26.2 million, with no debt.
Adjusted EBITDA was minus AUD 2 million; NPAT before amortization was minus AUD 1.2 million, and NPAT was minus AUD 8 million, reflecting investment in growth and subscription transition.
Record 80 contract wins and 19 renewals secured a forward revenue book of AUD 50.9 million over five years.
Board and executive committee updates
Significant board renewal brought new perspectives and skills; Rebecca Thompson joined as non-executive director.
Remuneration structure changed, discontinuing director options in response to investor feedback.
Board and management alignment on refreshed strategy and regular engagement with key investors; increased APAC/ME team capabilities.
Latest events from Mach7 Technologies
- Record recurring revenue and sales orders drive positive cash flow and strong FY25 outlook.M7T
H2 202429 May 2026 - Revenue up 33%, recurring revenue covers 80% of OpEx, positive EBITDA, and share buy-back announced.M7T
H1 202529 May 2026 - 16% revenue growth, recurring revenue covers 80% of OPEX, and cash flow is positive.M7T
H2 202529 May 2026 - Revenue fell 23% year-over-year, but recurring revenue and cost discipline support future growth.M7T
H1 202629 May 2026 - Q3 FY26 saw positive cash flow, ARR growth, and a strong cash position amid cost discipline.M7T
Q3 202624 Apr 2026 - Stable ARR, positive cash flow, and new product traction support a confident outlook.M7T
Q2 20263 Feb 2026 - Sales orders up 52%, recurring revenue and cash at record highs, subscription growth strong.M7T
Q4 2024 TU2 Feb 2026 - CARR and ARR rose in Q1 FY25, with strong cash reserves and reaffirmed growth guidance.M7T
Q1 2025 TU17 Jan 2026 - Recurring revenue up 15.6%, strong cash, and FY25 growth guidance reaffirmed.M7T
Q2 2025 TU9 Jan 2026